Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 09, 2024 Filed Apr 11, 2024 16:10 UTC |
Gu EhongInterim CFO
|
Disposition to issuerOrdinary Shares | 17,889 | $0.32 | $5,724.48 |
DisclosureSEC source: 0001990498-24-000005 · wk-form4_1712866199.xml · nonDerivative · entry 2 Gu Ehong · CIK 0001990498 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:25 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001062993-24-003732 · form4.xml · derivative · entry 11 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 Underlying: Ordinary Shares · 36,300 shares Expires 2032-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · ownership.nature: Represents securities held by Konstanin Poukalov. Mr. Poukalov is affiliated with the Advisor. The Advisor may be deemed to have an indirect pecuniary interest in the securities of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Poukalov's board service through a partial management fee offset. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:25 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001062993-24-003732 · form4.xml · derivative · entry 10 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Ordinary Shares · 36,300 shares Expires 2032-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Represents securities held by Adam Stone. Mr. Stone is the Chief Investment Officer of Perceptive Advisors, LLC (the "Advisor"). The Advisor may be deemed to have an indirect pecuniary interest in the securities of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Stone's board service through a partial management fee offset. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:25 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
Tax withholdingOrdinary Shares | 19,218 | $4.76 | $91,477.68 |
DisclosureSEC source: 0001062993-24-003732 · form4.xml · nonDerivative · entry 4 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 17,082 F2 · ownership.nature: Represents securities held by Konstanin Poukalov. Mr. Poukalov is affiliated with the Advisor. The Advisor may be deemed to have an indirect pecuniary interest in the securities of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Poukalov's board service through a partial management fee offset. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:25 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
Exercise / conversionOrdinary Shares | 36,300 | $2.52 | $91,476.00 |
DisclosureSEC source: 0001062993-24-003732 · form4.xml · nonDerivative · entry 3 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 36,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · ownership.nature: Represents securities held by Konstanin Poukalov. Mr. Poukalov is affiliated with the Advisor. The Advisor may be deemed to have an indirect pecuniary interest in the securities of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Poukalov's board service through a partial management fee offset. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:25 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
Tax withholdingOrdinary Shares | 19,218 | $4.76 | $91,477.68 |
DisclosureSEC source: 0001062993-24-003732 · form4.xml · nonDerivative · entry 2 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 17,082 F1 · ownership.nature: Represents securities held by Adam Stone. Mr. Stone is the Chief Investment Officer of Perceptive Advisors, LLC (the "Advisor"). The Advisor may be deemed to have an indirect pecuniary interest in the securities of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Stone's board service through a partial management fee offset. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:25 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
Exercise / conversionOrdinary Shares | 36,300 | $2.52 | $91,476.00 |
DisclosureSEC source: 0001062993-24-003732 · form4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 36,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Represents securities held by Adam Stone. Mr. Stone is the Chief Investment Officer of Perceptive Advisors, LLC (the "Advisor"). The Advisor may be deemed to have an indirect pecuniary interest in the securities of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Stone's board service through a partial management fee offset. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:27 UTC |
Poukalov KonstantinDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001062993-24-003733 · form4.xml · derivative · entry 3 Poukalov Konstantin · CIK 0001678736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 36,300 shares Expires 2032-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:27 UTC |
Poukalov KonstantinDirector
|
Tax withholdingOrdinary Shares | 19,218 | $4.76 | $91,477.68 |
DisclosureSEC source: 0001062993-24-003733 · form4.xml · nonDerivative · entry 2 Poukalov Konstantin · CIK 0001678736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,082 Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:27 UTC |
Poukalov KonstantinDirector
|
Exercise / conversionOrdinary Shares | 36,300 | $2.52 | $91,476.00 |
DisclosureSEC source: 0001062993-24-003733 · form4.xml · nonDerivative · entry 1 Poukalov Konstantin · CIK 0001678736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:23 UTC |
Stone Adam LeoDirector · Interim CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001062993-24-003729 · form4.xml · derivative · entry 3 Stone Adam Leo · CIK 0001727440 · Director · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 36,300 shares Expires 2032-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:23 UTC |
Stone Adam LeoDirector · Interim CEO
|
Tax withholdingOrdinary Shares | 19,218 | $4.76 | $91,477.68 |
DisclosureSEC source: 0001062993-24-003729 · form4.xml · nonDerivative · entry 2 Stone Adam Leo · CIK 0001727440 · Director · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,082 Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:23 UTC |
Stone Adam LeoDirector · Interim CEO
|
Exercise / conversionOrdinary Shares | 36,300 | $2.52 | $91,476.00 |
DisclosureSEC source: 0001062993-24-003729 · form4.xml · nonDerivative · entry 1 Stone Adam Leo · CIK 0001727440 · Director · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:11 UTC |
GIANAKAKOS ANASTASIOSDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001831283-24-000011 · wk-form4_1708463476.xml · derivative · entry 4 GIANAKAKOS ANASTASIOS · CIK 0001413822 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 36,300 shares Expires 2032-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares underlying the option became exercisable in full on June 23, 2023. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:11 UTC |
GIANAKAKOS ANASTASIOSDirector
|
Tax withholdingOrdinary Shares | 19,218 | $4.76 | $91,477.68 |
DisclosureSEC source: 0001831283-24-000011 · wk-form4_1708463476.xml · nonDerivative · entry 2 GIANAKAKOS ANASTASIOS · CIK 0001413822 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,630 Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:11 UTC |
GIANAKAKOS ANASTASIOSDirector
|
Exercise / conversionOrdinary Shares | 36,300 | $2.52 | $91,476.00 |
DisclosureSEC source: 0001831283-24-000011 · wk-form4_1708463476.xml · nonDerivative · entry 1 GIANAKAKOS ANASTASIOS · CIK 0001413822 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:10 UTC |
Silbermann Susan MicheleDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001831283-24-000010 · wk-form4_1708463411.xml · derivative · entry 3 Silbermann Susan Michele · CIK 0001887214 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 36,300 shares Expires 2032-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares underlying the option became exercisable in full on June 23, 2023. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:10 UTC |
Silbermann Susan MicheleDirector
|
Tax withholdingOrdinary Shares | 19,218 | $4.76 | $91,477.68 |
DisclosureSEC source: 0001831283-24-000010 · wk-form4_1708463411.xml · nonDerivative · entry 2 Silbermann Susan Michele · CIK 0001887214 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,082 Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:10 UTC |
Silbermann Susan MicheleDirector
|
Exercise / conversionOrdinary Shares | 36,300 | $2.52 | $91,476.00 |
DisclosureSEC source: 0001831283-24-000010 · wk-form4_1708463411.xml · nonDerivative · entry 1 Silbermann Susan Michele · CIK 0001887214 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2024 Filed Apr 11, 2024 16:10 UTC |
Gu EhongInterim CFO
|
SaleOrdinary Shares | 1,731 | $4.34 | $7,512.54 |
DisclosureSEC source: 0001990498-24-000005 · wk-form4_1712866199.xml · nonDerivative · entry 1 Gu Ehong · CIK 0001990498 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,762 F1 · balance_after: Represents the sale of shares to cover personal income tax obligations upon vesting of restricted share units ('RSUs') as required pursuant to the terms of Ms. Gu's RSU award agreement. 41,078 RSUs were granted to Ms. Gu under the LianBio 2021 Equity Incentive Plan (the 'Plan') on December 31, 2021, 25% of which vested on each of December 31, 2022 and 2023 with the remainder to vest in 25% annual installments and to be fully vested on December 31, 2025, subject to Ms. Gu's providing continuous service to the Issuer on each such date. On March 22, 2024, the board of directors of the Issuer resolved to terminate the Plan and any unvested RSUs granted thereunder in accordance with the terms of the Plan, effective as of March 24, 2024. In accordance with this determination, 58,873 unvested RSUs previously reported as beneficially owned by Ms. Gu were cancelled. Ms. Gu received no value in exchange for the cancellation of the unvested RSUs. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:09 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001062993-23-013979 · form4.xml · derivative · entry 2 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 36,300 Underlying: Ordinary Shares · 36,300 shares Expires 2033-06-21 F2 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable in full on June 21, 2024, the first anniversary of the grant date, subject to Konstantin Poukalov providing continuous service to the Issuer through such date. F4 · ownership.nature: Consists of options to purchase shares of the Issuer's ordinary shares awarded to Mr. Poukalov in connection with his role as a member of the Issuer's Board of Directors. Mr. Poukalov is affiliated with the Advisor. The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase ordinary shares of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Poukalov's board service through a partial management fee offset. F5 · ownership.nature: Joseph Edelman is the managing member of the Advisor. The Advisor serves as the investment manager of Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Each of Mr. Edelman, the Master Fund and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this form, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman, the Master Fund or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:09 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001062993-23-013979 · form4.xml · derivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 36,300 Underlying: Ordinary Shares · 36,300 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable in full on June 21, 2024, the first anniversary of the grant date, subject to Adam Stone providing continuous service to the Issuer through such date. F3 · ownership.nature: Consists of options to purchase shares of the Issuer's ordinary shares awarded to Mr. Stone in connection with his role as a member of the Issuer's Board of Directors. Mr. Stone is the Chief Investment Officer of Perceptive Advisors, LLC (the "Advisor"). The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase ordinary shares of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Stone's board service through a partial management fee offset. F5 · ownership.nature: Joseph Edelman is the managing member of the Advisor. The Advisor serves as the investment manager of Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Each of Mr. Edelman, the Master Fund and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this form, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman, the Master Fund or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:23 UTC |
Chen Wei WeiDirector
|
GrantStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001831283-23-000095 · wk-form4_1687551779.xml · derivative · entry 1 Chen Wei Wei · CIK 0001919307 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,300 Underlying: Ordinary Shares · 36,300 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable in full on June 21, 2024, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:22 UTC |
GIANAKAKOS ANASTASIOSDirector
|
GrantStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001831283-23-000094 · wk-form4_1687551713.xml · derivative · entry 1 GIANAKAKOS ANASTASIOS · CIK 0001413822 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,300 Underlying: Ordinary Shares · 36,300 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable in full on June 21, 2024, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:20 UTC |
Silbermann Susan MicheleDirector
|
GrantStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001831283-23-000093 · wk-form4_1687551598.xml · derivative · entry 1 Silbermann Susan Michele · CIK 0001887214 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,300 Underlying: Ordinary Shares · 36,300 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable in full on June 21, 2024, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:11 UTC |
Stone Adam LeoDirector
|
GrantStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001062993-23-013981 · form4.xml · derivative · entry 1 Stone Adam Leo · CIK 0001727440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,300 Underlying: Ordinary Shares · 36,300 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable in full on June 21, 2024, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:10 UTC |
Poukalov KonstantinDirector
|
GrantStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001062993-23-013980 · form4.xml · derivative · entry 1 Poukalov Konstantin · CIK 0001678736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,300 Underlying: Ordinary Shares · 36,300 shares Expires 2033-06-21 F1 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable in full on June 21, 2024, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date. Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 20:21 UTC |
Jahn BrianneChief Business Officer
|
GrantOrdinary Shares | 224,005 | $0.00 | $0.00 |
DisclosureSEC source: 0001831283-23-000054 · wf-form4_168029408142979.xml · nonDerivative · entry 1 Jahn Brianne · CIK 0001885012 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,005 F1 · shares: Represents restricted share units granted to the Reporting Person under the LianBio 2021 Equity Incentive Plan. Each restricted share unit represents the contingent right to receive one share of the Issuer's Ordinary Shares. 25% of the restricted share units shall vest on March 29, 2024; the remainder shall vest in 25% annual installments such that the restricted share units are fully vested on March 29, 2027, subject to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 20:20 UTC |
QIAN JIANGSVP, China General Manager
|
GrantOrdinary Shares | 224,005 | $0.00 | $0.00 |
DisclosureSEC source: 0001831283-23-000053 · wf-form4_168029404088883.xml · nonDerivative · entry 1 QIAN JIANG · CIK 0001880938 · SVP, China General Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,354 F1 · shares: Represents restricted share units granted to the Reporting Person under the LianBio 2021 Equity Incentive Plan. Each restricted share unit represents the contingent right to receive one share of the Issuer's Ordinary Shares. 25% of the restricted share units shall vest on March 29, 2024; the remainder shall vest in 25% annual installments such that the restricted share units are fully vested on March 29, 2027, subject to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 20:18 UTC |
Wang YizheDirector · Chief Executive Officer
|
GrantOrdinary Shares | 907,498 | $0.00 | $0.00 |
DisclosureSEC source: 0001831283-23-000052 · wf-form4_168029388148981.xml · nonDerivative · entry 1 Wang Yizhe · CIK 0001884248 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 907,498 F1 · shares: Represents restricted share units granted to the Reporting Person under the LianBio 2021 Equity Incentive Plan. Each restricted share unit represents the contingent right to receive one share of the Issuer's Ordinary Shares. 25% of the restricted share units shall vest on March 29, 2024; the remainder shall vest in 25% annual installments such that the restricted share units are fully vested on March 29, 2027, subject to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 20:17 UTC |
Larson YiChief Financial Officer
|
GrantOrdinary Shares | 325,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001831283-23-000051 · wf-form4_168029382182313.xml · nonDerivative · entry 1 Larson Yi · CIK 0001785987 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 325,901 F1 · shares: Represents restricted share units granted to the Reporting Person under the LianBio 2021 Equity Incentive Plan. Each restricted share unit represents the contingent right to receive one share of the Issuer's Ordinary Shares. 25% of the restricted share units shall vest on March 29, 2024; the remainder shall vest in 25% annual installments such that the restricted share units are fully vested on March 29, 2027, subject to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:11 UTC |
Jahn BrianneChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 318,995 | $0.00 Strike: $2.66 | $0.00 |
DisclosureSEC source: 0001831283-23-000017 · wf-form4_167459467623989.xml · derivative · entry 1 Jahn Brianne · CIK 0001885012 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,995 Underlying: Ordinary Shares · 318,995 shares Expires 2033-01-20 F1 · derivative.exercise_date: 25% of the shares underlying the option will vest and become exercisable on January 20, 2024; the remainder shall vest and become exercisable in 36 equal monthly installments such that the option shall be fully vested on January 20, 2027, subject to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:12 UTC |
Larson YiChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 464,099 | $0.00 Strike: $2.66 | $0.00 |
DisclosureSEC source: 0001831283-23-000018 · wf-form4_167459472625760.xml · derivative · entry 1 Larson Yi · CIK 0001785987 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,099 Underlying: Ordinary Shares · 464,099 shares Expires 2033-01-20 F1 · derivative.exercise_date: 25% of the shares underlying the option will vest and become exercisable on January 20, 2024; the remainder shall vest and become exercisable in 36 equal monthly installments such that the option shall be fully vested on January 20, 2027, subject to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:09 UTC |
QIAN JIANGSVP, China General Manager
|
GrantStock Option (Right to Buy) · Derivative | 318,995 | $0.00 Strike: $2.66 | $0.00 |
DisclosureSEC source: 0001831283-23-000016 · wf-form4_167459457187041.xml · derivative · entry 1 QIAN JIANG · CIK 0001880938 · SVP, China General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,995 Underlying: Ordinary Shares · 318,995 shares Expires 2033-01-20 F1 · derivative.exercise_date: 25% of the shares underlying the option will vest and become exercisable on January 20, 2024; the remainder shall vest and become exercisable in 36 equal monthly installments such that the option shall be fully vested on January 20, 2027, subject to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:08 UTC |
Wang YizheDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 1,292,324 | $0.00 Strike: $2.66 | $0.00 |
DisclosureSEC source: 0001831283-23-000015 · wf-form4_167459451349704.xml · derivative · entry 1 Wang Yizhe · CIK 0001884248 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,292,324 Underlying: Ordinary Shares · 1,292,324 shares Expires 2033-01-20 F1 · derivative.exercise_date: 25% of the shares underlying the option will vest and become exercisable on January 20, 2024; the remainder shall vest and become exercisable in 36 equal monthly installments such that the option shall be fully vested on January 20, 2027, subject to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:29 UTC |
QIAN JIANGSVP, China General Manager
|
SaleOrdinary Shares | 2,239 | $1.65 | $3,701.51 |
DisclosureSEC source: 0001831283-23-000002 · wf-form4_167295415423471.xml · nonDerivative · entry 1 QIAN JIANG · CIK 0001880938 · SVP, China General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,349 F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted share units as required pursuant to the terms of Mr. Qian's restricted share unit award agreement. Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 13:17 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
LEV LB Holdings, LPDirector · 10% owner
Perceptive Xontogeny Venture Fund, LPDirector · 10% owner
C2 Life Sciences LLCDirector · 10% owner
Perceptive Venture Advisors, LLCDirector · 10% owner
LEV LB Holdings GP, LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
PurchaseAmerican Depositary Shares | 998,240 | $2.40 | $2,395,776.00 |
DisclosureSEC source: 0001062993-22-018544 · form4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner LEV LB Holdings, LP · CIK 0001789443 · Director · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · Director · 10% owner C2 Life Sciences LLC · CIK 0001890152 · Director · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · Director · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,728,491 F5 · balance_after: Each American Depositary Share represents one Ordinary Share of the Issuer. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 21:38 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001062993-22-015491 · form4.xml · derivative · entry 2 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 36,000 Underlying: Ordinary Shares · 36,000 shares Expires 2032-06-23 F2 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable in full on June 23, 2023, the first anniversary of the grant date, subject to Adam Stone providing continuous service to the Issuer through such date. F4 · ownership.nature: Consists of options to purchase shares of the Issuer's ordinary shares awarded to Konstantin Poukalov in connection with his role as a member of the Issuer's Board of Directors. Mr. Poukalov is affiliated with the Advisor. The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase ordinary shares of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Poukalov's board service through a partial management fee offset. F5 · ownership.nature: Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this form, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 21:38 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001062993-22-015491 · form4.xml · derivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 36,000 Underlying: Ordinary Shares · 36,000 shares Expires 2032-06-23 F1 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable in full on June 23, 2023, the first anniversary of the grant date, subject to Konstantin Poukalov providing continuous service to the Issuer through such date. F3 · ownership.nature: Consists of options to purchase shares of the Issuer's ordinary shares awarded to Adam Stone in connection with his role as a member of the Issuer's Board of Directors. Mr. Stone is the Chief Investment Officer of Perceptive Advisors, LLC (the "Advisor"). The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase ordinary shares of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Stone's board service through a partial management fee offset. F5 · ownership.nature: Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this form, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 21:37 UTC |
Poukalov KonstantinDirector
|
GrantStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001062993-22-015490 · form4.xml · derivative · entry 1 Poukalov Konstantin · CIK 0001678736 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,300 Underlying: Ordinary Shares · 36,300 shares Expires 2032-06-23 F1 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable in full on June 23, 2023, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 21:36 UTC |
Stone Adam LeoDirector
|
GrantStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001062993-22-015489 · form4.xml · derivative · entry 1 Stone Adam Leo · CIK 0001727440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,300 Underlying: Ordinary Shares · 36,300 shares Expires 2032-06-23 F1 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable in full on June 23, 2023, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 20:17 UTC |
GIANAKAKOS ANASTASIOSDirector
|
GrantOrdinary Shares · Derivative | 36,300 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001831283-22-000050 · wf-form4_165636106038470.xml · derivative · entry 1 GIANAKAKOS ANASTASIOS · CIK 0001413822 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,300 Underlying: Ordinary Shares · 36,300 shares Expires 2032-06-23 F1 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable in full on June 23, 2023, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 20:17 UTC |
Silbermann Susan MicheleDirector
|
GrantStock Option (Right to Buy) · Derivative | 36,300 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001831283-22-000049 · wf-form4_165636102658025.xml · derivative · entry 1 Silbermann Susan Michele · CIK 0001887214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,300 Underlying: Ordinary Shares · 36,300 shares Expires 2032-06-23 F1 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable in full on June 23, 2023, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date. Read SEC document |
| May 26, 2022 Filed May 27, 2022 14:06 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
LEV LB Holdings, LPDirector · 10% owner
Perceptive Xontogeny Venture Fund, LPDirector · 10% owner
C2 Life Sciences LLCDirector · 10% owner
Perceptive Venture Advisors, LLCDirector · 10% owner
LEV LB Holdings GP, LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
PurchaseAmerican Depositary Shares | 69,000 | $3.13 | $215,970.00 |
DisclosureSEC source: 0001062993-22-013616 · form4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner LEV LB Holdings, LP · CIK 0001789443 · Director · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · Director · 10% owner C2 Life Sciences LLC · CIK 0001890152 · Director · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · Director · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,730,251 F5 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.065 to $3.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of purchased at each separate price within such range. F6 · balance_after: Each American Depositary Share represents one Ordinary Share of the Issuer. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| May 25, 2022 Filed May 25, 2022 22:51 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
LEV LB Holdings, LPDirector · 10% owner
Perceptive Xontogeny Venture Fund, LPDirector · 10% owner
C2 Life Sciences LLCDirector · 10% owner
Perceptive Venture Advisors, LLCDirector · 10% owner
LEV LB Holdings GP, LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
PurchaseAmerican Depositary Shares | 120,000 | $2.63 | $315,600.00 |
DisclosureSEC source: 0001062993-22-013535 · form4.xml · nonDerivative · entry 3 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner LEV LB Holdings, LP · CIK 0001789443 · Director · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · Director · 10% owner C2 Life Sciences LLC · CIK 0001890152 · Director · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · Director · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,661,251 F7 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.49 to $2.70, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of purchased at each separate price within such range. F8 · balance_after: Each American Depositary Share represents one Ordinary Share of the Issuer. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| May 24, 2022 Filed May 25, 2022 22:51 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
LEV LB Holdings, LPDirector · 10% owner
Perceptive Xontogeny Venture Fund, LPDirector · 10% owner
C2 Life Sciences LLCDirector · 10% owner
Perceptive Venture Advisors, LLCDirector · 10% owner
LEV LB Holdings GP, LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
PurchaseAmerican Depositary Shares | 42,551 | $2.47 | $105,100.97 |
DisclosureSEC source: 0001062993-22-013535 · form4.xml · nonDerivative · entry 2 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner LEV LB Holdings, LP · CIK 0001789443 · Director · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · Director · 10% owner C2 Life Sciences LLC · CIK 0001890152 · Director · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · Director · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,541,251 F6 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.36 to $2.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of purchased at each separate price within such range. F8 · balance_after: Each American Depositary Share represents one Ordinary Share of the Issuer. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| May 23, 2022 Filed May 25, 2022 22:51 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
LEV LB Holdings, LPDirector · 10% owner
Perceptive Xontogeny Venture Fund, LPDirector · 10% owner
C2 Life Sciences LLCDirector · 10% owner
Perceptive Venture Advisors, LLCDirector · 10% owner
LEV LB Holdings GP, LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
PurchaseAmerican Depositary Shares | 8,700 | $2.49 | $21,663.00 |
DisclosureSEC source: 0001062993-22-013535 · form4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner LEV LB Holdings, LP · CIK 0001789443 · Director · 10% owner Perceptive Xontogeny Venture Fund, LP · CIK 0001757940 · Director · 10% owner C2 Life Sciences LLC · CIK 0001890152 · Director · 10% owner Perceptive Venture Advisors, LLC · CIK 0001890130 · Director · 10% owner LEV LB Holdings GP, LLC · CIK 0001890132 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,498,700 F5 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.46 to $2.51, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of purchased at each separate price within such range. F8 · balance_after: Each American Depositary Share represents one Ordinary Share of the Issuer. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. ("Perceptive Life"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to Perceptive Life. Joseph Edelman is the managing member of the Advisor. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| May 04, 2022 Filed May 6, 2022 20:15 UTC |
Yu DebraSee Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000,000 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0000899243-22-017091 · doc4.xml · derivative · entry 2 Yu Debra · CIK 0001869480 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 999,947 Underlying: Ordinary Shares · 1,000,000 shares Expires 2030-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/3 of the shares underlying the option vested and became exercisable on January 1, 2020; 1/3 of the shares underlying the option vested and became exercisable on October 1, 2020 and 1/3 of the shares underlying the option vested and became exercisable on October 1, 2021, subject to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document |
| May 04, 2022 Filed May 6, 2022 20:15 UTC |
Yu DebraSee Remarks
|
Exercise / conversionOrdinary Shares | 1,000,000 | $1.71 | $1,710,000.00 |
DisclosureSEC source: 0000899243-22-017091 · doc4.xml · nonDerivative · entry 1 Yu Debra · CIK 0001869480 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:27 UTC |
Chen Wei WeiDirector
|
GrantStock Option (Right to Buy) · Derivative | 72,600 | $0.00 Strike: $4.95 | $0.00 |
DisclosureSEC source: 0000899243-22-014353 · doc4.xml · derivative · entry 1 Chen Wei Wei · CIK 0001919307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,600 Underlying: Ordinary Shares · 72,600 shares Expires 2032-04-06 F1 · derivative.exercise_date: 1/36 of the shares underlying the option will become exercisable on 05/06/2022; the remainder shall vest and become exercisable in 35 equal monthly installments such that the option shall be fully vested on 04/06/2025, subject to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.